Lillys Zepbound, approved in November 2023 as the Indiana-based drug giants answer to Novo Nordisks Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase 3 trial, and a mid-stage study of another Lilly experimental medicine, called retatrutide, showed 24% weight loss after just 48 weeks
Potential Benefits: Stimulates collagen and elastin production, supporting firmer, more youthful skin Promotes hair follicle growth and scalp health Enhances wound healing and tissue regeneration Improves skin elasticity and reduces fine lines Offers antioxidant and anti-inflammatory protection Supports nerve regeneration and recovery from injury May improve cognitive function and reduce anxiety in early studies Helps maintain healthy blood vessels and circulation Assists in balancing copper metabolism in the body Potential Side Effects While generally considered safe when used topically or under clinical guidance, some individuals may experience: Temporary skin irritation or redness Sensitivity at the application site Rare allergic reactions The science of GHK-Cu is evolving, but this small copper-binding peptide continues to attract attention for its broad applications in dermatology, regenerative medicine, and healthy aging
When this happens tyrosine phosphorylation becomes less likely to happen
In reality, no, Ipamorelin does not typically make you hungry
This telehealth model allows for regular check-ins, helping to promptly address side effects and optimize the benefits of treatment while minimizing risks
